Platelet function testing: does a randomized controlled trial settle the debate?
- 14 July 2015
- journal article
- editorial
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 8 (8), 768-769
- https://doi.org/10.1136/neurintsurg-2015-011954
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Standard vs Modified Antiplatelet Preparation for Preventing Thromboembolic Events in Patients With High On-Treatment Platelet Reactivity Undergoing Coil Embolization for an Unruptured Intracranial AneurysmJAMA Neurology, 2015
- Role of phenotypic and genetic testing in managing clopidogrel therapyBlood, 2014
- Antiplatelet testing in neurointervention: we cannot ignore the signsJournal of NeuroInterventional Surgery, 2013
- Point of care platelet function testing in routine neurointerventional care is unjustifiedJournal of NeuroInterventional Surgery, 2013
- Bedside Monitoring to Adjust Antiplatelet Therapy for Coronary StentingNew England Journal of Medicine, 2012
- Hemorrhagic complications with prasugrel therapy for vascular neurointerventional proceduresJournal of NeuroInterventional Surgery, 2012
- Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary InterventionJAMA, 2011
- Novel use of prasugrel for intracranial stent thrombosisJournal of NeuroInterventional Surgery, 2011
- Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17British Journal of Clinical Pharmacology, 2010
- Clinical Significance of the Cytochrome P450 2C19 Genetic PolymorphismClinical Pharmacokinetics, 2002